Eight-milligram single dose of buprenorphine as an expeditious treatment for severe suicidal ideation: A case report

5Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Introduction: Buprenorphine is used to treat opioid use disorder and pain syndromes. This drug may be a suitable treatment choice for refractory depression, anxiety, self-injurious behaviors, and suicidal ideation. However, it has a significant abuse potential, which limits its use in suicidal patients with a history of substance abuse. Case Report: In this report, we present a case of chronic suicidal ideation due to substance-induced depressive disorder in a 25-yearoldmanfrom Noorabad, Fars, Iran. The patient was successfully treated with an 8-mg single dose of sublingual buprenorphine with minimal probability of diversion or misuse. We observed that 8 mg of buprenorphine exerted a rapid effect on the reduction and cessation of suicidal thoughts and depression. Conclusions: We demonstrated the antisuicidal effectiveness of a single dose of buprenorphine, which can be administered with minimum risk of diversion or misuse for suicidal patients with a history of substance abuse.

Cite

CITATION STYLE

APA

Ahmadi, J., & Abtahi, S. (2017). Eight-milligram single dose of buprenorphine as an expeditious treatment for severe suicidal ideation: A case report. Iranian Red Crescent Medical Journal, 19(9). https://doi.org/10.5812/ircmj.59999

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free